Riggs Asset Management’s Novavax NVAX Stock Holding History

Riggs Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-108	Closed	-$803	–	430
2023 Q2	$803	Hold	108	–	–	﹤0.01%	353
2023 Q1	$749	Buy	+108	New	+$994	﹤0.01%	329

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Riggs Asset Management's NVAX Position: Q3 2023 in Review

Riggs Asset Management sold out of Novavax (NVAX) in Q3 2023, closing a stake of 108 shares — an estimated $803 sold.

Riggs Asset Management first reported a position in NVAX in Q1 2023 and held it in 2 quarters. The position peaked at $803 in Q2 2023. 225 funds tracked by Wall St. Rank hold NVAX as of Q3 2023.

Riggs Asset Management reported no remaining Novavax position as of Q3 2023 after selling out during the quarter.
Riggs Asset Management sold 108 Novavax shares in Q3 2023, an estimated $803.
Riggs Asset Management first reported a position in Novavax in Q1 2023 and held it in 2 quarters.
Riggs Asset Management's Novavax position peaked at $803 in Q2 2023.
225 funds tracked by Wall St. Rank held Novavax as of Q3 2023.

Based on Riggs Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.